UC-MSC and Secretome for respiratory distress syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Dec 2023: Trial started, NCT07439848
  2. 27 Feb 2026: Trial registered, NCT07439848

The trials

NCT07439848: Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis

State
Under way
Phase
Phase 1 and Phase 2
People
15 planned
Started
25 Dec 2023
Primary completion
Dec 2026
Arms
Mesenchymal Stem Cell (UC-MSC) + Secretome
Results
None posted
  1. 25 Dec 2023: Trial started
  2. 27 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.